EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting

Sanaz Sadeh, Amir Ghaemi iD, Nazila Arbab Soleimani, Majid Moghbeli, Golnaz BahramAli

PLOS One · 2025

DOI: 10.1371/journal.pone.0338028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Sanaz Sadeh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Damghan Branch, Islamic Azad University, Damghan, Iran. Hauptthemen laut MEDLINE: Cell-Penetrating Peptides, Orthomyxoviridae. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pasteur Institute of Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Successful antigen delivery is of paramount importance for successful vaccination. Cell-penetrating peptides (CPPs) offer a highly effective means of delivering antigens, nucleic acids, and other drug compounds to cells. However, their mechanisms of action remain poorly understood and require further investigation. This study sought to identify novel CPPs within the influenza virus proteome using computational screening methods for vaccine and antigen delivery. CPP candidates were screened from major influenza proteins using CellPPD, C2Pred, and PreTP-EL. Their efficiencies in uptake, physicochemical properties, and safety profiles were assessed using MLCPP, ProtParam, IEDB, ToxinPred, and AllerTop. Structural properties were assessed using AlphaFold, and binding interactions with the lung-targeting sialic acid analog LSTc were investigated using molecular docking and molecular dynamics simulations. Of the CPPs discovered, PB1-derived peptides, especially PB1−1 (RGDTQIQTRR), exhibit high membrane permeability and strong affinity for sialic acid receptors, along with low predicted toxicity and promising intracellular delivery capacity. PB1−1 forms a stable complex with LSTc, which pointed towards its potential for receptor-mediated lung targeting. The identified influenza-derived CPPs have strong therapeutic potential owing to their high predicted uptake efficiency, good safety profiles, and capacity for binding to lung-specific sialic acid receptors, suggesting their suitability for targeted vaccine or antigen delivery. These peptides take advantage of viral-mimetic entry pathways, including clathrin/caveolae-mediated endocytosis and direct membrane permeation, to efficiently deliver therapeutic cargo into cells. Cumulatively, our results suggest that influenza-derived CPPs, particularly PB1−1, may be suitable candidates for respiratory therapy and vaccine delivery. However, given the purely computational scope, the results should be considered hypothesis-generating and require experimental validation in vitro and in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Penetrating PeptidesOrthomyxoviridaeHumansMolecular Docking SimulationAnimalsMolecular Dynamics SimulationInfluenza VaccinesDrug Delivery SystemsMadin Darby Canine Kidney CellsViral ProteinsDogs

Substanzen

Cell-Penetrating PeptidesInfluenza VaccinesViral Proteins

Autor:innen und Institutionen

  • Department of Microbiology, Damghan Branch, Islamic Azad University, Damghan, Iran.
  • Department of Influenza and other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran.
  • Hepatitis and AIDS Department, Pasteur Institute of Iran, Tehran, Iran.

ORCID-Profile: Amir Ghaemi

Förderung

  • Pasteur Institute of Iran

Zitieren

APA

Sadeh, S., Ghaemi, A., Soleimani, N. A., Moghbeli, M., & BahramAli, G. (2025). Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting. PLOS One. https://doi.org/10.1371/journal.pone.0338028

Vancouver

Sadeh S, Ghaemi A, Soleimani NA, Moghbeli M, BahramAli G. Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting. PLOS One. 2025. doi:10.1371/journal.pone.0338028

BibTeX
@article{Sadeh2025,
  author = {Sadeh, Sanaz and Ghaemi, Amir and Soleimani, Nazila Arbab and Moghbeli, Majid and BahramAli, Golnaz},
  title = {Designing influenza virus-derived cell-penetrating peptides for antigen delivery: Integrating uptake efficiency, safety, and receptor targeting},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338028}
}
Kostenlos starten →